Acupuncture treatment for dizziness after repositioning for BPPV
Effect of Head Acupuncture on Residual Symptoms After Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo: a Single-center Randomized Controlled Trial.
This study is testing if electroacupuncture can help people aged 18-65 with lingering dizziness after treatment for BPPV feel better compared to a common medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Xi'an No.3 Hospital Government |
| Locations | 1 site (Xi'an) |
| Trial ID | NCT06001047 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of electroacupuncture in treating residual symptoms of benign paroxysmal positional vertigo (BPPV) after successful repositioning maneuvers. Patients aged 18-65 diagnosed with BPPV will be recruited and assessed for residual symptoms following their treatment. The study aims to explore risk factors for these symptoms, evaluate gait characteristics, and compare the efficacy of electroacupuncture against betahistine. The research will take place at the Third Hospital of Xi'an City from June 2023 to June 2024.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 who have been diagnosed with BPPV and have persistent symptoms after successful repositioning.
Not a fit: Patients with other ear diseases, those who are pregnant, or individuals who have undergone vestibular rehabilitation may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from residual symptoms of BPPV.
How similar studies have performed: While electroacupuncture has shown promise in treating dizziness in other vestibular disorders, the specific application for residual BPPV symptoms is less explored, making this a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful.
2. After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted.
3. There were no obvious communication barriers or visual impairments.
4. The patient and their family members agreed to the treatment plan.
Exclusion Criteria:
* Patients with other ear diseases, history of head trauma or surgery;
* Patients who are weak and unable to tolerate, pregnant women;
* Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.
Where this trial is running
Xi'an
- Xi'an No3 Hospital — Xi'an, China (Recruiting)
Study contacts
- Study coordinator: Mingze Chang, PhD
- Email: changmingze191@163.com
- Phone: 029+8661816100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.